Protagenic Therapeutics, Inc.\new — Revenue by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/1c379e7e-b8e0-4889-a5fa-5bd8aa5ca19d/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $0 | 2025-04-01 – 2026-03-31 | evidence 0001493152-26-038255 |
| FY 2024 | $0 | 2024-04-01 – 2025-03-31 | evidence 0001493152-26-038255 |
| FY 2023 | $0 | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-012333 |
| FY 2022 | $0 | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-010152 |
| FY 2021 | $0 | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-009370 |
| FY 2020 | $0 | 2020-01-01 – 2020-12-31 | evidence 0001493152-22-009370 |
| FY 2016 | $0 | 2016-01-01 – 2016-12-31 | evidence 0001437749-17-006686 |
| FY 2015 | $0 | 2015-01-01 – 2015-12-31 | evidence 0001437749-16-035178 |
| FY 2014 | $0 | 2014-01-01 – 2014-12-31 | evidence 0001437749-16-035178 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Protagenic Therapeutics, Inc.\new — all facts · Net Income · Operating Income